There’s been a lot of discussion this week about the First Amendment and the media. But the discussion about the First Amendment and pharma marketing has seemingly faded into the background since last December’s decision by a federal appeals court …

We’ve all heard a lot recently about content marketing, but for various reasons you may not have connected this phenomenon to a core competency of pharma. But Peter Houston, a former group content director at Advanstar Pharma Science and now …

It certainly seems that point-of-care media are getting more attention, from both life science companies looking for new opportunities to engage patients and with media companies looking to bolster their offerings to marketers. In just the past few days, we’ve …

Every once in awhile a creative person, or team, comes up with a new idea for telling an old story. In one of the latest examples of this, marketers and Boehringer Ingelheim and Eli Lilly – working with their agency …